Kiora Pharmaceuticals (NASDAQ:KPRX) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.71) by 18.31 percent. This is a 11.54 percent decrease over losses of $(0.52) per share from the same period last year.